4DMedicalASX:4DX -8.97%64 Gross Margin % is 93.00% as of Dec. 2025, which is 28% above its 10-year median of 72.77. GuruFocus rates ASX:4DX with a GF Score™ of 64/100 and a GF Value™ of A$1.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, 4DMedical ranks better than 97.02% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. 4DMedical's Gross Profit for the
six
months ended in Dec. 2025 was A$2.61 Mil. 4DMedical's Revenue for the
six
months ended in Dec. 2025 was A$2.80 Mil. Therefore, 4DMedical's Gross Margin % for the quarter that ended in Dec. 2025 was 93.00%.
The historical rank and industry rank for 4DMedical's Gross Margin % or its related term are showing as below:
ASX:4DX'
s Gross Margin % Range Over the Past 10 Years
Min: 9 Med: 72.77 Max: 92.23
Current: 91.7
During the past 6 years, the highestGross Margin % of 4DMedical was 92.23%. The lowest was 9.00%. And the median was 72.77%.
ASX:4DX's Gross Margin % is ranked better than 97.02% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:4DX: 91.70
4DMedical had a gross margin of 93.00% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for 4DMedical was 50.20% per year.
4DMedical (ASX:4DX) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
4DMedical had a gross margin of 93.00% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
4DMedical Gross Margin % Related Terms
4DMedical Gross Margin % Historical Data
* Premium members only.
The historical data trend for 4DMedical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:4DX vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, 4DMedical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where 4DMedical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
4DMedical (ASX:4DX) has a Gross Margin % of 93.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on 4DMedical and its competitors. This is 28% above median its historical median of 72.77. Over the past decade, 4DMedical's Gross Margin % has ranged from 9.00 to 92.23. According to the industry distribution chart, 4DMedical ranks #24 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 3%.
Is 4DMedical's Gross Margin % too high?
4DMedical's current Gross Margin % of 93.00% is 28% above median its 10-year median of 72.77. Over the past 10 years, this metric has ranged from a low of 9.00 to a high of 92.23. The Medical Devices & Instruments industry median Gross Margin % is 52.07. 4DMedical's value of 93.00% is 78.6% above this industry median. Based on the distribution chart, 4DMedical ranks #24 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 4DMedical has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #24 out of 805 companies for Gross Margin %. This places 4DMedical in the top 3% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. 4DMedical's value of 93.00% is 78.6% above this benchmark. Historically, 4DMedical's own Gross Margin % has ranged from 9.00 to 92.23 over the past decade. While the company's 10-year median is 72.77 vs. the industry median of 52.07, 4DMedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current Gross Margin % of 93.00% is 78.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Gross Margin % is 93.00%, which is 28% above median its own 10-year median of 72.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$1.44, compared to a current price of A$4.16 — trading 188.9% above its estimated fair value. The current Gross Margin % is 93.00%, which is 28% above median its 10-year median of 72.77 and 78.6% above the Medical Devices & Instruments industry median of 52.07. 4DMedical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current Gross Margin % is 93.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (ASX:4DX) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of A$4.16 is trading 188.9% above its estimated GF Value™ of A$1.44.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for ASX:4DX:
Gross Margin %: 93.00% (28% above median its 10-year median of 72.77)
GF Value™: A$1.44 vs. price of A$4.16 (188.9% above fair value)
Industry Position: 78.6% above the Medical Devices & Instruments median (#24 of 805)
No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
64GF Score
Get the complete analysis for ASX:4DX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:4DX has been successfully added to your 
